查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1890960

溶菌酶市場依治療用途、產品類型、劑型、給藥途徑、製劑類型、最終用戶、通路及地區分類

Lysozyme Market, By Therapeutic Application, By Product Type, By Form, By Route of Administration, By Formulation Type, By End User, By Distribution Channel, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

溶菌酶市場預計在 2025 年達到 6.059 億美元，預計到 2032 年將達到 9.922 億美元，2025 年至 2032 年的複合年成長率為 7.3%。

報告覆蓋範圍 報告詳情
基準年： 2024 2025年市場規模： 6.059億美元
歷史數據時期： 2020-2024 預測期： 2025-2032
預測期間（2025-2032年）： 7.30% 2032 年的預測值： 9.922億美元

溶菌酶是生物技術和製藥行業的重要組成部分，其全球市場成長主要得益於這種天然抗菌酶的多功能特性。溶菌酶主要來自蛋白、人體分泌物和細菌，是多種應用領域的關鍵成分，從食品保鮮到藥物製劑均有涉及。溶菌酶能夠分解細菌細胞壁，使其成為對抗微生物感染和延長多個產業產品保存期限的寶貴資源。

溶菌酶市場提供多種產品類型，包括蛋白來源的溶菌酶、人源溶菌酶和重組溶菌酶，每種產品都符合特定產業的需求。其主要應用領域包括食品飲料、藥品、個人保健產品和動物飼料，溶菌酶的天然抗菌特性使其成為合成防腐劑的永續替代方案。消費者對天然成分日益成長的偏好，以及食品安全和藥品品質監管框架的嚴格要求，使得溶菌酶成為尋求高效天然抗菌解決方案的製造商的首選。生物技術研究的進步、創新的生產方法以及在新興治療領域的應用拓展，進一步推動了市場的成長，使其成為一個充滿活力且不斷發展的領域，具有巨大的商業性潛力。

市場動態

全球溶菌酶市場受多種關鍵因素驅動，維持強勁成長動能。其中，食品、製藥和個人護理行業對天然抗菌劑的需求不斷成長是主要促進因素，因為消費者越來越重視潔淨標示產品，而製造商也在尋求合成防腐劑的替代品。食品飲料產業的擴張，尤其是在開發中國家，為溶菌酶在食品保鮮領域的應用創造了巨大的機會。同時，製藥業對天然治療化合物的日益重視，推動了藥物製劑和傷口護理應用中對藥用級溶菌酶的需求。此外，隨著人們對抗生素抗藥性的認知不斷提高，溶菌酶正逐漸成為一種極具吸引力的替代抗菌劑，大量研究表明其對多種致病微生物有效。

然而，市場仍面臨諸多限制因素。溶菌酶萃取和純化過程的高昂生產成本限制了其在成本敏感型應用領域和新興市場的應用。特別是，原料蛋清供應有限，給供應鏈帶來了挑戰；而複雜的區域性法規則阻礙了市場准入和產品標準化。在某些條件下，溶菌酶的儲存穩定性較差，且可能引起敏感族群的過敏反應，這些因素進一步限制了市場擴張。然而，生物技術的進步帶來了巨大的機遇，重組溶菌酶的生產克服了供應限制和致敏性問題，並有可能降低生產成本。不斷擴大的營養保健品市場、在獸醫領域的應用拓展、在發展中地區日益成長的應用，以及溶菌酶在多種疾病治療中的潛在應用，為那些尋求利用溶菌酶多樣化功能特性的市場參與企業提供了一條實現盈利成長的道路。

本次調查的主要特點

  • 本報告對全球溶菌酶市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模和複合年成長率（%）。
  • 我們將重點介紹各個細分市場的潛在商機，並說明該市場具有吸引力的投資提案矩陣。
  • 該研究還提供了有關市場促進因素、限制因素、機會、新產品發布或核准、市場趨勢、區域展望以及主要企業。
  • 本報告根據以下參數對全球溶菌酶市場的主要參與企業進行了分析：公司概況、產品系列、主要亮點、財務表現和策略。
  • 本報告的研究結果將使負責人和經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
  • 這份全球溶菌酶市場報告的目標受眾是該行業的各類相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過全球溶菌酶市場分析中使用的各種策略矩陣輕鬆做出決策。

目錄

第1章 研究目標與前提條件

  • 調查目的
  • 先決條件
  • 簡稱

第2章 市場範圍

  • 報告概述
    • 市場定義和範圍
  • 執行摘要

第3章：市場動態、監理及趨勢分析

  • 市場動態
  • 促進要素
  • 抑制因素
  • 機會
  • 影響分析
  • 法規環境
  • 產品上市及核准
  • PEST分析
  • 波特分析
  • 併購趨勢
  • 產業趨勢

4. 2020-2032年全球溶菌酶市場（依治療用途分類）

  • 抗感染治療
  • 抗發炎治療
  • 胃腸道感染疾病管理
  • 呼吸道感染疾病管理
  • 傷口護理和組織修復
  • 免疫調節療法
  • 其他

5. 2020-2032年全球溶菌酶市場（依產品類型分類）

  • 重組溶菌酶
  • 天然溶菌酶

6. 2020-2032年全球溶菌酶市場（依劑型分類）

  • 溶菌酶溶液
  • 溶菌酶粉

7. 2020-2032年全球溶菌酶市場依給藥途徑分類

  • 口服
  • 腸外
  • 外用
  • 其他（鼻內）

8. 2020-2032年全球溶菌酶市場（依製劑類型分類）

  • 單藥治療
  • 聯合治療

9. 2020-2032年全球溶菌酶市場（依最終用戶分類）

  • 製藥公司
  • 生技公司
  • 醫院和診所
  • 研究所

第10章 全球溶菌酶市場（依通路分類），2020-2032年

  • 線上
  • 離線

第11章 全球溶菌酶市場（按地區分類），2020-2032年

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲國家
  • 歐洲
    • 德國
    • 英國
    • 西班牙
    • 法國
    • 義大利
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • ASEAN
    • 亞太其他地區
  • 中東
    • GCC
    • 以色列
    • 其他中東國家
  • 非洲
    • 南非
    • 北非
    • 中非

第12章 競爭格局

  • dsm-firmenich
  • Bioseutica BV
  • WAKO Chemicals
  • Danish Bioscience
  • Qingdao Vland BIoTech
  • Amano Enzyme Inc
  • Lysozyme Corporation
  • Nanning Doing-Higher Bio-Tech
  • Jiangsu Yiming Biological
  • Jiangxi Shineway Pharmaceutical
  • Handary SA
  • Bouwhuis Enthoven
  • AgraFood Ingredients BV
  • Neova Technologies
  • Chr Hansen A/S

第13章 分析師建議

  • 機會
  • 一致的機會地圖

第14章 參考文獻與調查方法

  • 參考
  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI9004

Lysozyme Market is estimated to be valued at USD 605.9 Mn in 2025 and is expected to reach USD 992.2 Mn by 2032, growing at a compound annual growth rate (CAGR) of 7.3% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 605.9 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 7.30% 2032 Value Projection: USD 992.2 Mn

The global lysozyme market represents a significant segment within the biotechnology and pharmaceutical industries, driven by the multifunctional properties of this naturally occurring antimicrobial enzyme. Lysozyme, primarily derived from egg whites, human secretions, and bacterial sources, serves as a crucial component in various applications ranging from food preservation to pharmaceutical formulations. This enzyme's ability to break down bacterial cell walls makes it an invaluable asset in combating microbial infections and extending product shelf life across multiple industries.

The market encompasses diverse product types including egg white lysozyme, human lysozyme, and recombinant lysozyme, each serving specific industrial requirements. Key application sectors include food and beverages, pharmaceuticals, personal care products, and animal feed, where lysozyme's natural antimicrobial properties provide sustainable alternatives to synthetic preservatives. The increasing consumer preference for natural ingredients, coupled with stringent regulatory frameworks governing food safety and pharmaceutical quality, has positioned lysozyme as a preferred choice for manufacturers seeking effective yet natural antimicrobial solutions. The market's growth trajectory is further supported by advancing biotechnology research, innovative production methods, and expanding applications in emerging therapeutic areas, making it a dynamic and evolving sector with substantial commercial potential.

Market Dynamics

The global lysozyme market is propelled by several key drivers that collectively contribute to its robust growth trajectory, with the primary driver being the escalating demand for natural antimicrobial agents across food, pharmaceutical, and personal care industries as consumers increasingly prioritize clean-label products and manufacturers seek alternatives to synthetic preservatives. The expanding food and beverage sector, particularly in developing economies, creates substantial opportunities for lysozyme application in food preservation, while the growing pharmaceutical industry's focus on natural therapeutic compounds drives demand for pharmaceutical-grade lysozyme in drug formulations and wound healing applications. Additionally, the rising awareness of antibiotic resistance has positioned lysozyme as an attractive alternative antimicrobial agent, supported by extensive research demonstrating its efficacy against various pathogenic microorganisms.

However, the market faces significant restraints including the high production costs associated with lysozyme extraction and purification processes, which limit its adoption in cost-sensitive applications and emerging markets. Raw material availability constraints, particularly concerning egg white sources, pose supply chain challenges, while regulatory complexities across different regions create barriers to market entry and product standardization. The limited shelf stability of lysozyme under certain conditions and potential allergenic reactions in sensitive individuals further constrain market expansion. Nevertheless, substantial opportunities emerge from advancing biotechnology enabling recombinant lysozyme production, which addresses supply limitations and allergenicity concerns while potentially reducing production costs. The expanding nutraceutical market, growing applications in veterinary medicine, increasing adoption in developing regions, and potential therapeutic applications in treating various diseases present lucrative growth avenues for market participants seeking to capitalize on lysozyme's diverse functional properties.

Key Features of the Study

  • This report provides in-depth analysis of the global lysozyme market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global lysozyme market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include dsm-firmenich, Bioseutica BV, WAKO Chemicals, Danish Bioscience, Qingdao Vland Biotech, Amano Enzyme Inc, Lysozyme Corporation, Nanning Doing-Higher Bio-Tech, Jiangsu Yiming Biological, Jiangxi Shineway Pharmaceutical, Handary SA, Bouwhuis Enthoven, AgraFood Ingredients BV, Neova Technologies, and Chr Hansen A/S
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global lysozyme market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global lysozyme market

Market Segmentation

  • Therapeutic Application Insights (Revenue, USD Mn, 2020 - 2032)
    • Anti-infective Therapies
    • Anti-inflammatory Therapies
    • Gastrointestinal Infection Management
    • Respiratory Infection Management
    • Wound-Healing and Tissue Repair
    • Immunomodulatory Applications
    • Other Therapeutic Uses
  • Product Type Insights (Revenue, USD Mn, 2020 - 2032)
    • Recombinant Lysozyme
    • Natural Lysozyme
  • Form Insights (Revenue, USD Mn, 2020 - 2032)
    • Lysozyme Solution
    • Lysozyme Powder
  • Route of Administration Insights (Revenue, USD Mn, 2020 - 2032)
    • Oral
    • Parenteral
    • Topical
    • Others (Nasal)
  • Formulation Type Insights (Revenue, USD Mn, 2020 - 2032)
    • Monotherapies
    • Combination Therapies
  • End User Insights (Revenue, USD Mn, 2020 - 2032)
    • Pharmaceutical Manufacturers
    • Biotechnology Companies
    • Hospitals and Clinics
    • Research Institutes
  • Distribution Channel Insights (Revenue, USD Mn, 2020 - 2032)
    • Online
    • Offline
  • Regional Insights (Revenue, USD Mn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • dsm-firmenich
    • Bioseutica BV
    • WAKO Chemicals
    • Danish Bioscience
    • Qingdao Vland Biotech
    • Amano Enzyme Inc
    • Lysozyme Corporation
    • Nanning Doing-Higher Bio-Tech
    • Jiangsu Yiming Biological
    • Jiangxi Shineway Pharmaceutical
    • Handary SA
    • Bouwhuis Enthoven
    • AgraFood Ingredients BV
    • Neova Technologies
    • Chr Hansen A/S

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Lysozyme Market, By Therapeutic Application
    • Global Lysozyme Market, By Product Type
    • Global Lysozyme Market, By Form
    • Global Lysozyme Market, By Route of Administration
    • Global Lysozyme Market, By Formulation Type
    • Global Lysozyme Market, By End User
    • Global Lysozyme Market, By Distribution Channel
    • Global Lysozyme Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Lysozyme Market, By Therapeutic Application, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Anti-infective Therapies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Anti-inflammatory Therapies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Gastrointestinal Infection Management
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Respiratory Infection Management
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Wound-Healing and Tissue Repair
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Immunomodulatory Applications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Other Therapeutic Uses
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

5. Global Lysozyme Market, By Product Type, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Recombinant Lysozyme
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Natural Lysozyme
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Lysozyme Market, By Form, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Lysozyme Solution
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Lysozyme Powder
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Lysozyme Market, By Route of Administration, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Parenteral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Topical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Others (Nasal)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Lysozyme Market, By Formulation Type, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Monotherapies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Combination Therapies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

9. Global Lysozyme Market, By End User, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Pharmaceutical Manufacturers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Hospitals and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

10. Global Lysozyme Market, By Distribution Channel, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Online
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Offline
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

11. Global Lysozyme Market, By Region, 2020 - 2032, Value (USD Mn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Form, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Formulation Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Form, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Formulation Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Form, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Formulation Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Form, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Formulation Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Form, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Formulation Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Form, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Formulation Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
      • South Africa
      • North Africa
      • Central Africa

12. Competitive Landscape

  • dsm-firmenich
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bioseutica BV
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • WAKO Chemicals
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Danish Bioscience
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Qingdao Vland Biotech
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Amano Enzyme Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Lysozyme Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Nanning Doing-Higher Bio-Tech
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Jiangsu Yiming Biological
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Jiangxi Shineway Pharmaceutical
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Handary SA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bouwhuis Enthoven
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • AgraFood Ingredients BV
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Neova Technologies
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Chr Hansen A/S
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

13. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

14. References and Research Methodology

  • References
  • Research Methodology
  • About us